ReviewClinical liver disease2014
Causality assessment: Which is best-expert opinion or RUCAM?
Review in Clinical liver disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Model of baseline clinicopathological features predicts non-resolution of drug-induced liver injury at 6 months.Hepatology international · 2025Article
- Methods for causality assessment of idiosyncratic drug-induced liver injury.Liver international : official journal of the International Association for the Study of the Liver · 2025Review
- Probable Enoxaparin-Induced Liver Injury in a Young Patient: A Case Report of a Diagnostic Challenge.Cureus · 2023Article
- Hepatobiliary Events in Migraine Therapy with Herbs-The Case of Petadolex, A Petasites Hybridus Extract.Journal of clinical medicine · 2019Article
- The Development of a Database for Herbal and Dietary Supplement Induced Liver Toxicity.International journal of molecular sciences · 2018Article
- Heavy Consumption of Alcohol is Not Associated With Worse Outcomes in Patients With Idiosyncratic Drug-induced Liver Injury Compared to Non-Drinkers.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2018Article
- Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study.Alimentary pharmacology & therapeutics · 2018Article
- Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.Clinical drug investigation · 2018Observational
- Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury.International journal of molecular sciences · 2017Article
- Drug-induced liver injury: Do we know everything?World journal of hepatology · 2017Review
- Review
- Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps.Frontiers in pharmacology · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.